Introduction
Before the placement of an intravenous (IV) line in outpatient surgery settings, the reason behind implementing intradermal lidocaine administration must be addressed. The objective of this change is to minimize IV insertion-related pain, thereby enhancing patients’ experience and increasing their overall satisfaction. This move has been initiated with the central aim of considering patients’ comfort and satisfaction. For some patients, needle insertions, especially those involving IV lines, are usually distressing and lead to heightened anxiety and discomfort. This pain can be relieved by including intradermal lidocaine administration during outpatient procedures, thus making it more effective for the patient.
Several clinical studies have evaluated whether or not intradermal lidocaine decreases pain associated with IV cannulation. In one systematic review, Rzhevskiy et al. (2022) analyzed multiple randomized controlled trials and concluded that, compared with placebo or no intervention, intradermal lidocaine significantly reduced pain intensity during IV cannulation. Improving patient comfort, achieving better clinical outcomes, and adopting principles of patient-centered care are the goals that will drive future change.
Description of Health Care Setting
In a hospital outpatient surgical environment, the intended change will take place. A diverse patient population usually undergoes various surgeries that do not require overnight hospitalization in this setting. Patients, in this case, suffer from angst and pain due to knowledge of imminent medical procedures such as IV line placement (Rzhevskiy et al., 2022). The outpatient surgery unit uses a multidisciplinary team approach, encompassing surgeons, anesthesiologists, nurses, and support staff who work collaboratively to ensure efficient, high-quality care delivery.
Factors related to the community relevant to change include demographics, socioeconomic status, and culture. The hospital may serve people from different backgrounds, each affected by factors such as socioeconomic status, as well as whether they can afford medical services or how they feel about pain relief. Social beliefs and practices influencing health care might also hinder patients’ acceptance or use of intradermal lidocaine as a means of curbing pain.
Description of Those Impacted by Change
The above-mentioned change will significantly affect healthcare providers involved in outpatient surgical procedures, including surgeons, anesthesiologists, and nurses who administer lidocaine and insert IVs. Moreover, patients undergoing outpatient surgery will experience a direct impact, and they may be relieved of the pain and fear linked with intravenous cannulation (Marani et al., 2024). These changes will also indirectly affect hospital administrators, quality improvement teams, and other support staff who oversee this integration process, resource allocation, and outcome monitoring.
Description of Implications of Care
The use of intradermal lidocaine before IV line insertion is a significant step towards person-centered care in the organization. By making patient comfort and satisfaction paramount, this change aligns with the basic tenets of person-centered care, which prioritize patient choices, needs, and feelings. This demonstrates a commitment to their autonomy and dignity by offering patients the opportunity for pain relief during IV insertions, fostering a therapeutic relationship based on mutual respect and collaboration.
Regarding legal and ethical issues in nursing practice, there must be compliance with relevant laws, regulations, and ethical standards when implementing change processes. The American Nurses Association (ANA) Code of Ethics for Nurses provides guidance on ethical responsibilities in caring for patients. Provision 1.4 of the ANA Code specifically emphasizes that it is the nurse’s responsibility to diminish pain or suffering while promoting comfort and honoring human dignity (Grace & Uveges, 2022). There are also legal concerns, such as maintaining accurate documentation, obtaining informed consent, and adhering to institutional policies and protocols, among others.
Available Communication Networks
Within the organization, formal communication networks such as staff meetings, departmental emails, and policy updates provide a framework for disseminating information about the change process. Additionally, to raise awareness and gain support, informal networks such as word-of-mouth among staff and social interactions should not be forgotten. Therefore, a multifaceted approach will be adopted to ensure complete information dissemination through both informal and formal channels (Arya et al., 2021). This strategy encompasses issuing educational materials, conducting training sessions, speaking one-on-one with concerned individuals, and using digital platforms to disseminate resources and news about planned changes.
Planned Change Process
To improve the patient’s experience and reduce procedural pain characterized by anxiety during IV cannulation, the planned change process is to incorporate the use of intradermal lidocaine in an outpatient surgical setting before IV line placement. This will be accomplished by standardizing intradermal lidocaine use, enabling optimization of patient outcomes, enhancing staff satisfaction, and aligning with current best practices in pain management. To achieve this goal, several evidence-based practices will be integrated into existing protocols.
This initiative was based on Kotter’s 8-Step Model of Change theory. A renowned expert on change management, John Kotter, developed this model as a guideline for leading organizations through successful transformations (Haas et al., 2020). Creating urgency, establishing a guiding coalition, and empowering employees are among the main points of Kotter’s model. By following this example, an organization can overcome resistance effectively and introduce sustainable reforms to achieve desired results.
Steps Taken in the Change Process Following Kotter’s Model
- Create a Sense of Urgency: The first step is to implement changes that reflect a need for transformative action, as far as dealing with procedural pain when inserting IVs is concerned.
- Form a Guiding Coalition: There shall be a multi-disciplinary team composed of key stakeholders, including physicians and anesthesiologists, among others, who will lead the planned change process, hence making it successful.
- Develop a Vision and Strategy: The change team gives the change a vision that should be real, focusing on improved patient satisfaction and comfort through evidence-based pain management.
- Communicate the Vision: Achieving buy-in and alignment with the change process involves transparently and consistently communicating about the planned change program.
- Empower Broad-Based Action: Employees at the clinical level are empowered to actively participate in this change initiative to enhance their commitment to it.
- Generate Short-Term Wins: Celebrating early wins and milestones helps build momentum while instilling motivation in stakeholders to support the change process, as well as reminding patients and other health workers of the successful application effects of intradermal lidocaine, which helps relieve procedural pains.
- Consolidate Gains and Produce More Change: Ongoing efforts must now focus on consolidating these achievements while dealing with any remaining barriers or challenges as implementation shifts from being a new project activity into routine practice.
- Providing a new basis in the culture: The organization further includes intradermal lidocaine and other evidence-based pain management strategies within its culture and SOPs as it aims to sustain itself in the future.
Positive Expected Outcomes
The change process is expected to yield several positive outcomes for patients and healthcare providers. First of all, it will lead to decreased pain and anxiety felt by patients during IV insertion, resulting in improved satisfaction and overall experience. By ensuring patient comfort and well-being, organizations demonstrate their commitment to patient-centered care, thereby laying the foundation for building trust among patients.
Measurement of Change Process Impact
The change process’s impact shall be measured using two methods: qualitative research and quantitative approaches, such as patient feedback surveys, clinical outcome data, and process indicators. Qualitative methods include interviews, focus groups, observations, or combinations thereof. Patient satisfaction surveys will help measure perceptions of pain management effectiveness, ease of IV insertion, and the overall outpatient surgical experience (Ali & Nater, 2020). To examine how intradermal lidocaine administration affects patient outcomes, the analysis will be done on clinical outcomes data, which includes rates for procedural complications, adverse events, and patient-reported scores on painfulness.
Justification for Change
The anticipated revision to include intradermal administration of lidocaine prior to IV line placement comes with a good rationale for various stakeholders in the healthcare system. For healthcare providers, particularly outpatient surgical nurses and clinicians, it seeks to minimize patient fear and misery, which will translate into increased job satisfaction and morale. The change greatly impacts patients by offering them less pain and better comfort while having an IV placed, thus increasing their satisfaction with the care received.
Regarding quality care, implementing intradermal lidocaine is consistent with evidence-based practices for patient-centered care that optimizes clinical outcomes. Furthermore, it offers safety implications by reducing risks associated with IV insertions, such as needle-stick injuries, phlebitis, and infection (Rzhevskiy et al., 2022). Besides, this type of change supports risk management efforts by addressing typical sources of discomfort for patients, thereby reducing the likelihood of patient complaints, litigation, or adverse consequences.
Managing Resources
For the execution and assessment of this change program, it is essential to manage resources. These include human and financial resources. Additional fiscal expenditures may be required to obtain needles for intradermal lidocaine administration, support personnel training programs, or acquire technology infrastructure to collect and analyze data. Human resource allocation for change implementation also necessitates dedicated employees like trainers, educators, and project managers (Hunt & Malhotra, 2022). Furthermore, data collection tools, analysis software, performance monitoring, and evaluation staff are important in improving service quality on an ongoing basis so as to measure the effects of a change or drive continuous improvement efforts.
Conclusion
The anticipated outcomes of using intradermal lidocaine prior to IV line insertion in outpatient surgical settings are numerous. First, the implementation will result in considerable pain and anxiety relief for patients undergoing procedures. This will make their care experiences more comfortable and satisfying. It is also expected that this change will improve patient experience, leading to increased loyalty and confidence on the part of patients towards health care providers.
Secondly, it is projected that the use of evidence-based pain management approaches would lead to better clinical outcomes, such as reduced procedural complications, as well as adverse events attributable to IV insertion rates. Thus, the organization’s focus on promoting a safe healthcare environment through improved practices of managing pain addresses its commitment to minimize hazards like needle stick injuries and infections, among others, which usually occur during different procedural moments in order to protect both patients and healthcare workers. In brief, these desired results include higher patient satisfaction rates, improved clinical outcomes, enhanced safety measures, and a more patient-centered approach to treatment delivery at outpatient surgery centers.
References
Ali, N., & Nater, U. M. (2020). Salivary alpha-amylase as a biomarker of stress in behavioral medicine. International Journal of Behavioral Medicine, 27, 337-342.
Arya, V., Arora, G., Kumar, S., Kaur, A., & Mishra, S. (2021). Management of patients with allergy to local anesthetics: two case reports. Journal of dental anesthesia and pain medicine, 21(6), 583-587.
Grace, P. J., & Uveges, M. K. (2022). Nursing ethics and professional responsibility in advanced practice. Jones & Bartlett Learning.
Haas, M. R., Munzer, B. W., Santen, S. A., Hopson, L. R., Haas, N. L., Overbeek, D., Peterson, W., Cranford, J. & Huang, R. D. (2020). # DidacticsRevolution: Applying Kotter’s 8-Step Change Management Model to Residency Didactics. Western Journal of Emergency Medicine, 21(1), 65-70.
Hunt, S. V., & Malhotra, R. (2022). Bacteriostatic preserved saline for pain-free periocular injections. Eye, 36(8), 1546-1552.
Marani, A., Gioacchini, H., Paolinelli, M., Bobyr, I., Martina, E., Radi, G., Diotalallevi, F. & Campanati, A. (2024). Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness. Toxins, 16(1), 1-11.
Rzhevskiy, A., Popov, A., Pavlov, C., Anissimov, Y., Zvyagin, A., Levin, Y., & Kochba, E. (2022). Intradermal injection of lidocaine with a microneedle device to provide rapid local anesthesia for peripheral intravenous cannulation: A randomized open-label placebo-controlled clinical trial. Plos one, 17(1), 1-13.